(Q83210290)
Statements
Disability outcomes and dose escalation with etanercept, adalimumab, and infliximab in rheumatoid arthritis patients: a US-based retrospective comparative effectiveness study (English)
V F Schabert
B Bruce
C F Ferrufino
D R Globe
D J Harrison
B Lingala